نتائج البحث

M2 macrophage derived HMOX1 defines chronic rhinosinusitis with nasal polyps.

• Authors : Wang, Enhao^1,2,3 (AUTHOR); Hao, Yanghe^1,2,3 (AUTHOR); Song, Jing^1,2,3 (AUTHOR)

• Source: Clinical & Translational Allergy. Dec2024, Vol. 14 Issue 12, p1-12. 12p.

تفاصيل العنوان

Clinical Efficacy among Patients with Chronic Rhinosinusitis with Nasal Polyps and Clinical Features of Obstructive Lung Disease: Post Hoc Analysis of the Phase III SINUS-24 and SINUS-52 Studies

• Authors : Maspero, JF; Bachert, C; Martinez, FJ

Subjects: Medicin och hälsovetenskap

• Source: Journal of asthma and allergy. 16:333-342

تفاصيل العنوان

A Study of Lebrikizumab (LY3650150) in Adult Participants With Chronic Rhinosinusitis and Nasal Polyps Treated With Intranasal Corticosteroids (CONTRAST-NP)

• Source: A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Efficacy and Safety Study of Lebrikizumab/ LY3650150 in Adults With Chronic

تفاصيل العنوان

A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Participants with Chronic Rhinosinusitis with Nasal Polyps (VIBRANT)

• Source: A Phase 2, Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of Verekitug (UPB-101) in Participants with Chronic

تفاصيل العنوان

A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal Polyps

• Source: A Cohort Study on Biomarkers to Predict the Efficacy of Biologics for Chronic Rhinosinusitis with Nasal

تفاصيل العنوان

A Proof-of-Concept Study to Assess the Efficacy, Safety and Tolerability of Itepekimab (Anti--IL-33 mAb) in Participants With Chronic Rhinosinusitis Without Nasal Polyps

• Authors : Regeneron Pharmaceuticals

• Source: A Randomized, Double-blind, Placebo-controlled, Proof-of-Concept (PoC) Study to Assess the Efficacy, Safety and Tolerability of Itepekimab in Participants With Inadequately Controlled

تفاصيل العنوان

Efficacy and Safety of Depemokimab (GSK3511294) in Participants With Chronic Rhinosinusitis With Nasal Polyps (ANCHOR-2) (ANCHOR-2)

• Source: A Randomised, Double-blind, Parallel Group Phase III Study to Assess the Efficacy and Safety of 100 mg SC Depemokimab in Patients With Chronic

تفاصيل العنوان

Regulatory Post-Marketing Surveillance of Xolair® for Chronic Rhinosinusitis With Nasal Polyps

• Source: Regulatory Post-Marketing Surveillance (rPMS) of Xolair® (Xolair® 150mg Powder for Solution for Injection, Xolair® 150mg/1ml Liquid in Pre-filled Syringe, Xolair® 75mg/0.5ml Liquid in Pre-filled

تفاصيل العنوان

Risk factors investigation for different outcomes between unilateral and bilateral chronic rhinosinusitis with nasal polyps patients.

• Authors : Wang, Jianwei^1,2,3 (AUTHOR); Zhang, Yu^2,3 (AUTHOR); Chen, Ying^2,3,4 (AUTHOR)

• Source: Clinical & Translational Allergy. Sep2024, Vol. 14 Issue 9, p1-11. 11p.

تفاصيل العنوان

A Proof-of-concept Study of Lunsekimig Compared With Placebo in Adults With Chronic Rhinosinusitis With Nasal Polyps

• Source: A Randomized Phase 2, Double-blind, Placebo-controlled, Parallel-group, 2-arm Study to Assess the Efficacy, Safety, and Tolerability of Subcutaneous Lunsekimig in Adult Participants With

تفاصيل العنوان